comparemela.com

Latest Breaking News On - Respiratory drugs - Page 1 : comparemela.com

Global Cystic Fibrosis Market Analysis & 10 Year Forecast

Dublin, April 09, 2024 (GLOBE NEWSWIRE) The

South koreaUnited kingdomUnited statesSouth africaResearch methodologyBristol myers squibbAdministration segment opportunity analysisVertex pharmaceuticals incorporatedCompany profiles of topGilead sciencesCompany market share analysisDrug administrationAdministration estimates trend analysisCystic fibrosis foundationCompany profilesRoute of administration

Global Montelukast Sodium Market Report 2024: A USD 2 24

Dublin, March 28, 2024 (GLOBE NEWSWIRE) The

South africaSouth koreaUnited statesUnited kingdomZydus cadilaGlenmark pharmaceuticals ltdJubilant life sciences ltdMerck coReddy laboratories ltdCompany profiles of the topApotex incEuropean medicines agencyTorrent pharmaceuticals ltdPfizer incAurobindo pharmaTeva pharmaceutical industries ltd

Global Cystic Fibrosis Lung Disease Market Forecasts

Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) The

United kingdomUnited statesPorter five forces analysisRoute of administrationCystic fibrosis lung disease marketAnalysis by drug typeDistribution channelMarket insightsCystic fibrosis lung diseaseHospital pharmaciesRetail pharmaciesMiddle eastFive forces analysisResearch and marketsYstic fibrosis therapeuticRespiratory drugs

AstraZeneca, Pfizer Inc , and Novartis AG Spearhead

Dublin, July 20, 2023 (GLOBE NEWSWIRE) The "Tuberculosis Therapeutics Market Size, Share & Trends Analysis Report By Disease Type (Active TB,.

Eli lillyKey emerging companiesViatris incSun pharmaceutical industries ltdPfizer incPublic companiesJohnson services incKey company market share analysisTeva pharmaceutical industries ltdRoche ltdWorld health organizationCompany categorizationRegional networkRoute of administration business analysisTherapeutics market sizeTrends analysis report by disease type

Global Respiratory Disease Partnering Analysis Report 2023:

Dublin, June 01, 2023 (GLOBE NEWSWIRE) The "Global Respiratory Partnering 2010-2023: Deal Trends, Players and Financials" report has been added to .

United statesUnited kingdomMedidata solutionsHealth careGlenmark pharmaceuticalsMelinda gates foundationLaboratory corporation of americaDrug administrationCasi pharmaceuticalsSichuan universityAlnylam pharmaceuticalsFoundation for sarcoidosis researchBiostar pharmaceuticalsAmyndas pharmaceuticalsInnovative genomics initiativeHighmark health

vimarsana © 2020. All Rights Reserved.